John Aballi

Insider Reports History

Entity
Individual
Location
C/O Decipher Biosciences, Inc., 6925 Lusk Blvd, Suite 200, San Diego, CA
Signature
/s/ Kamal Adawi, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Aballi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EXAGEN INC. President and CEO, Director Common Stock 601K $1.15M $1.92 May 16, 2024 Direct
EXAGEN INC. President and CEO, Director Common Stock 40.4K $77.6K $1.92 May 16, 2024 by Spouse

Insider Reports Filed by John Aballi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XGN EXAGEN INC. May 16, 2024 1 $77.6K 4 May 16, 2024 President and CEO, Director
XGN EXAGEN INC. Feb 29, 2024 1 $18.7K 4 Mar 4, 2024 President and CEO, Director
XGN EXAGEN INC. Feb 20, 2024 1 $0 4 Feb 22, 2024 President and CEO, Director
XGN EXAGEN INC. Oct 17, 2023 1 -$59K 4 Oct 18, 2023 President and CEO, Director
XGN EXAGEN INC. Aug 31, 2023 1 $21K 4 Sep 6, 2023 President and CEO, Director
XGN EXAGEN INC. Dec 8, 2022 1 $241K 4 Dec 9, 2022 President and CEO, Director
XGN EXAGEN INC. Oct 16, 2022 1 $0 4 Oct 18, 2022 President and CEO, Director
XGN EXAGEN INC. Oct 16, 2022 0 $0 3 Oct 18, 2022 President and CEO, Director